Christopher Gibson - Sep 6, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Sep 6, 2023
Transactions value $
-$439,942
Form type
4
Date filed
9/8/2023, 05:01 PM
Previous filing
Aug 17, 2023
Next filing
Sep 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $77.5K +31.3K +3.58% $2.48 905K Sep 6, 2023 Direct F1
transaction RXRX Class A Common Stock Sale -$297K -33.8K -3.73% $8.78 871K Sep 6, 2023 Direct F1, F2
transaction RXRX Class A Common Stock Conversion of derivative security $0 +4K $0.00 4K Sep 6, 2023 By LAHWRAN-3 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale -$35.3K -4K -100% $8.83 0 Sep 6, 2023 By LAHWRAN-3 LLC F1, F4, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +20K $0.00 20K Sep 6, 2023 By LAHWRAN-4 LLC F1, F3, F6
transaction RXRX Class A Common Stock Sale -$177K -20K -100% $8.83 0 Sep 6, 2023 By LAHWRAN-4 LLC F1, F2, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1K $0.00 1K Sep 6, 2023 By Gibson Family Trust F1, F3, F7
transaction RXRX Class A Common Stock Sale -$8.84K -1K -100% $8.84 0 Sep 6, 2023 By Gibson Family Trust F1, F7, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31.3K -5.88% $0.00 500K Sep 6, 2023 Class A Common Stock 31.3K $2.48 Direct F1, F11
transaction RXRX Class B Common Stock Conversion of derivative security $0 -4K -0.76% $0.00 523K Sep 6, 2023 Class A Common Stock 4K $0.00 by LAHWRAN-3 LLC F1, F3, F4, F12
transaction RXRX Class B Common Stock Conversion of derivative security $0 -20K -4.27% $0.00 448K Sep 6, 2023 Class A Common Stock 20K $0.00 by LAHWRAN-4 LLC F1, F3, F6, F12
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1K -0.82% $0.00 121K Sep 6, 2023 Class A Common Stock 1K $0.00 by Gibson Family Trust F1, F3, F7, F12
holding RXRX Stock Option (Right to Buy) 814K Sep 6, 2023 Class A Common Stock 0 $8.55 Direct F9
holding RXRX Stock Option (Right to Buy) 5.44K Sep 6, 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 408K Sep 6, 2023 Class A Common Stock 0 $11.40 Direct F10
holding RXRX Class B Common Stock 6.52M Sep 6, 2023 Class A Common Stock 0 $0.00 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $8.61 to $9.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Represents the conversion of Class B Common Stock into Class A Common Stock.
F4 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F5 This transaction was executed in multiple trades at prices ranging from $8.65 to $9.09. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F7 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F8 This transaction was executed in multiple trades at prices ranging from $8.65 to $9.05. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F11 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F12 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.